Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors

“Although aberrant promoter DNA hypermethylation is a hallmark of cancer, it is not clear whether it is sufficient to drive transformation. Here, the authors use CRISPR-dCas9 to perform hit-and-run epigenetic editing, which prevents senescence entry in primary breast cells from healthy donors.”

Bibliographic Details
Main Authors: Emily A. Saunderson, Peter Stepper, Jennifer J. Gomm, Lily Hoa, Adrienne Morgan, Michael D. Allen, J. Louise Jones, John G. Gribben, Tomasz P. Jurkowski, Gabriella Ficz
Format: Article
Language:English
Published: Nature Portfolio 2017-11-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-017-01078-2
_version_ 1819129473482620928
author Emily A. Saunderson
Peter Stepper
Jennifer J. Gomm
Lily Hoa
Adrienne Morgan
Michael D. Allen
J. Louise Jones
John G. Gribben
Tomasz P. Jurkowski
Gabriella Ficz
author_facet Emily A. Saunderson
Peter Stepper
Jennifer J. Gomm
Lily Hoa
Adrienne Morgan
Michael D. Allen
J. Louise Jones
John G. Gribben
Tomasz P. Jurkowski
Gabriella Ficz
author_sort Emily A. Saunderson
collection DOAJ
description “Although aberrant promoter DNA hypermethylation is a hallmark of cancer, it is not clear whether it is sufficient to drive transformation. Here, the authors use CRISPR-dCas9 to perform hit-and-run epigenetic editing, which prevents senescence entry in primary breast cells from healthy donors.”
first_indexed 2024-12-22T08:44:17Z
format Article
id doaj.art-cc5d45d93ae34cfa90c771738264e95a
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-22T08:44:17Z
publishDate 2017-11-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-cc5d45d93ae34cfa90c771738264e95a2022-12-21T18:32:09ZengNature PortfolioNature Communications2041-17232017-11-018111510.1038/s41467-017-01078-2Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donorsEmily A. Saunderson0Peter Stepper1Jennifer J. Gomm2Lily Hoa3Adrienne Morgan4Michael D. Allen5J. Louise Jones6John G. Gribben7Tomasz P. Jurkowski8Gabriella Ficz9Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary University of LondonInstitute for Biochemistry and Technical Biochemistry, Department of Biochemistry, Faculty of Chemistry, University of StuttgartBarts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary University of LondonBarts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary University of LondonBarts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary University of LondonBarts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary University of LondonBarts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary University of LondonBarts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary University of LondonInstitute for Biochemistry and Technical Biochemistry, Department of Biochemistry, Faculty of Chemistry, University of StuttgartBarts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary University of London“Although aberrant promoter DNA hypermethylation is a hallmark of cancer, it is not clear whether it is sufficient to drive transformation. Here, the authors use CRISPR-dCas9 to perform hit-and-run epigenetic editing, which prevents senescence entry in primary breast cells from healthy donors.”https://doi.org/10.1038/s41467-017-01078-2
spellingShingle Emily A. Saunderson
Peter Stepper
Jennifer J. Gomm
Lily Hoa
Adrienne Morgan
Michael D. Allen
J. Louise Jones
John G. Gribben
Tomasz P. Jurkowski
Gabriella Ficz
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors
Nature Communications
title Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors
title_full Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors
title_fullStr Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors
title_full_unstemmed Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors
title_short Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors
title_sort hit and run epigenetic editing prevents senescence entry in primary breast cells from healthy donors
url https://doi.org/10.1038/s41467-017-01078-2
work_keys_str_mv AT emilyasaunderson hitandrunepigeneticeditingpreventssenescenceentryinprimarybreastcellsfromhealthydonors
AT peterstepper hitandrunepigeneticeditingpreventssenescenceentryinprimarybreastcellsfromhealthydonors
AT jenniferjgomm hitandrunepigeneticeditingpreventssenescenceentryinprimarybreastcellsfromhealthydonors
AT lilyhoa hitandrunepigeneticeditingpreventssenescenceentryinprimarybreastcellsfromhealthydonors
AT adriennemorgan hitandrunepigeneticeditingpreventssenescenceentryinprimarybreastcellsfromhealthydonors
AT michaeldallen hitandrunepigeneticeditingpreventssenescenceentryinprimarybreastcellsfromhealthydonors
AT jlouisejones hitandrunepigeneticeditingpreventssenescenceentryinprimarybreastcellsfromhealthydonors
AT johnggribben hitandrunepigeneticeditingpreventssenescenceentryinprimarybreastcellsfromhealthydonors
AT tomaszpjurkowski hitandrunepigeneticeditingpreventssenescenceentryinprimarybreastcellsfromhealthydonors
AT gabriellaficz hitandrunepigeneticeditingpreventssenescenceentryinprimarybreastcellsfromhealthydonors